These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2897995

  • 1. Withdrawal of endogenous somatostatin induces secretion of growth hormone-releasing factor in rats.
    Miki N, Ono M, Shizume K.
    J Endocrinol; 1988 May; 117(2):245-52. PubMed ID: 2897995
    [Abstract] [Full Text] [Related]

  • 2. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
    Painson JC, Tannenbaum GS.
    Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
    [Abstract] [Full Text] [Related]

  • 3. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion.
    Tannenbaum GS, Ling N.
    Endocrinology; 1984 Nov; 115(5):1952-7. PubMed ID: 6149116
    [Abstract] [Full Text] [Related]

  • 4. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC, Tannenbaum GS.
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D, Bruno JF, Wood TL, Gelato MC, Leidy JW, Gilbert JM, Berelowitz M.
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [Abstract] [Full Text] [Related]

  • 7. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin.
    Lanzi R, Tannenbaum GS.
    Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739
    [Abstract] [Full Text] [Related]

  • 8. The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release.
    Clark RG, Carlsson LM, Rafferty B, Robinson IC.
    J Endocrinol; 1988 Dec; 119(3):397-404. PubMed ID: 2906083
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The effects of PGE2, 2-DG and L-arginine on hypothalamic GHRH and SRIF releases in conscious rats, with respect to GH secretion].
    Kimura S, Kameyama K, Hosoi E, Saito S.
    Nihon Naibunpi Gakkai Zasshi; 1989 Feb 20; 65(2):113-27. PubMed ID: 2568278
    [Abstract] [Full Text] [Related]

  • 11. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS, McCarthy GF, Zeitler P, Beaudet A.
    Endocrinology; 1990 Nov 20; 127(5):2551-60. PubMed ID: 1977581
    [Abstract] [Full Text] [Related]

  • 12. Involvement of hypothalamic growth hormone (GH)-releasing factor in GH secretion induced by intracerebroventricular injection of somatostatin in rats.
    Murakami Y, Kato Y, Kabayama Y, Inoue T, Koshiyama H, Imura H.
    Endocrinology; 1987 Jan 20; 120(1):311-6. PubMed ID: 2877864
    [Abstract] [Full Text] [Related]

  • 13. Somatostatin prevents the desensitizing action of growth hormone-releasing factor on growth hormone release.
    Simard J, Lefèvre G, Labrie F.
    Peptides; 1987 Jan 20; 8(2):199-205. PubMed ID: 2884644
    [Abstract] [Full Text] [Related]

  • 14. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
    Stachura ME, Tyler JM, Farmer PK.
    Endocrinology; 1988 Sep 20; 123(3):1476-82. PubMed ID: 2900135
    [Abstract] [Full Text] [Related]

  • 15. Effect of withdrawal of somatostatin and growth hormone (GH)-releasing factor on GH release in vitro.
    Kraicer J, Sheppard MS, Luke J, Lussier B, Moor BC, Cowan JS.
    Endocrinology; 1988 May 20; 122(5):1810-5. PubMed ID: 2896117
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of alpha-methyl-p-tyrosine and an antiserum to rat growth hormone (GH)-releasing factor (GRF) on plasma GH secretory profile during a continuous infusion of human GRF in rats.
    Sugihara H, Wakabayashi I, Minami S, Takahashi F, Shibasaki T, Ling N.
    Brain Res; 1988 Dec 13; 475(1):128-33. PubMed ID: 3145782
    [Abstract] [Full Text] [Related]

  • 19. Hormone ontogeny in the ovine fetus and neonate. XXII. The effect of somatostatin on the growth hormone (GH) response to GH-releasing factor.
    de Zegher F, Daaboul J, Grumbach MM, Kaplan SL.
    Endocrinology; 1989 Mar 13; 124(3):1114-7. PubMed ID: 2563681
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor.
    Lengyel AM, Tannenbaum GS.
    Endocrinology; 1987 Apr 13; 120(4):1377-83. PubMed ID: 2881773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.